Millions of molecules exist and some of them can treat diseases.
We still need to know which ones.
Artificial intelligence (AI) tools are already being tested to help predict the evolution of cancers or analyze x-rays.
They could tomorrow design effective drugs in a very short time thanks to their computing power.
Advances in this thriving sector are at the heart of discussions at the unmissable annual biotechnology meeting, the “Healthcare Conference”, which ended this Thursday, January 11 in San Francisco (United States).
The rest after this ad
Popularized at the end of 2022 by ChatGPT, generative AI finds another outlet than prose writing or image design.
Its powerful algorithms would be able to find the magic chemical formula that cures.
“It became an essential method when no one in the pharmaceutical industry thought that generative artificial intelligence could help solve complex cases when the first scientific articles came out in 2019,” rewinds Alex Zhavoronkov, CEO of Insilico Medicine, a start-up developing a treatment for pulmonary fibrosis.
Subscribe
Already subscribed?
To log in